Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.